Aptose Biosciences, Inc. (APTO)

NASDAQ: APTO · Delayed Price · USD
1.24
0.01 (0.81%)
At close: Jan 26, 2022 4:00 PM
1.22
-0.02 (-1.61%)
After-hours:Jan 26, 2022 5:44 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019201820172016201520142013201220112010 - 2000
Selling, General & Admin
26.4810.0210.375.556.447.990.0101.791.79
Upgrade
Research & Development
29.2916.8418.736.277.834.87001.61.86
Upgrade
Operating Expenses
55.7726.8629.1111.8314.2712.860.0103.43.65
Upgrade
Operating Income
-55.77-26.86-29.11-11.83-14.27-12.86-0.01-0-3.4-3.65
Upgrade
Interest Expense / Income
00000.050.03000.010.05
Upgrade
Other Expense / Income
-0.53-0.58-0.24-0.18-0.08-1.18-0-0-0-0.01
Upgrade
Pretax Income
-55.24-26.28-28.87-11.64-14.24-11.71-0.01-0-3.41-3.69
Upgrade
Net Income
-55.24-26.28-28.87-11.64-14.24-11.71-0.01-0-3.41-3.69
Upgrade
Net Income Common
-55.24-26.28-28.87-11.64-14.24-11.71-0.01-0-3.41-3.69
Upgrade
Shares Outstanding (Basic)
8250332213125421
Upgrade
Shares Outstanding (Diluted)
8250332213125421
Upgrade
Shares Change
63.15%50.22%49.65%75.10%7.03%128.26%48.14%108.56%53.99%-
Upgrade
EPS (Basic)
-0.67-0.52-0.86-0.52-1.12-0.98-1.49-1.17-2.04-3.37
Upgrade
EPS (Diluted)
-0.67-0.52-0.86-0.52-1.12-0.98-1.49-1.17-2.04-3.37
Upgrade
Free Cash Flow Per Share
-0.41-0.43-0.70-0.46-0.97-0.85-1.21-1.07-1.45-3.93
Upgrade
EBITDA
-54.62-25.66-28.78-11.56-14.08-11.60.010.02-3.36-3.59
Upgrade
EBIT
-55.24-26.28-28.87-11.64-14.19-11.68-0.01-0-3.39-3.64
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).